Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer

Clinical trial NCT01535157 · TERMINATED

Trial details

NCT number: NCT01535157
Sponsor: South Plains Oncology Consortium
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Cancer of Ovary Cancer of the Ovary Ovary Neoplasms Primary Peritoneal Carcinoma

Start date: 2012-02-01
Primary completion: 2017-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.